December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

A New Question for Chronic Pain

A new clinical feature–based self-referral tool shows promise for speeding the diagnosis of axial spondyloarthritis.

Conexiant

December 10, 2025

Medical Oddities: Hot Flashes, Prepare to Be Hypnotized

Your weekly grab bag: mouthwash spice, hypnotic cool-downs, muscle tea, fiber fixes, telomere buzz.

Conexiant

December 10, 2025

Dual Therapy Shows Bone Promise

Adding romosozumab to ongoing denosumab therapy boosted bone formation and improved spine density in postmenopausal women with severe osteoporosis.

Conexiant

December 08, 2025

RA Clues Detected Months Prior

Key markers signaled RA risk earlier than expected in relatives of adults with RA.

Conexiant

December 05, 2025

Top 10 States to Practice Rheumatology

The following list highlights the states that offer the most favorable conditions for rheumatologists.

Conexiant

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 17, 2025

Active PsA Linked to Maternal Hypertension in Pregnancy

Researchers explore links between psoriatic arthritis and maternal health.

Conexiant